United Kingdom
Argentina 
Australia 
Austria 
Brazil 
Canada 
Germany 
Ireland 
Italy 
Malaysia 
Mexico 
New Zealand 
Poland 
South Africa 
United States GSK plc
Shareholders Approve N657.73 Million Dividend
GlaxoSmithKline Consumer Nigeria Plc shareholders have approved the payment of N657.73 million as dividends at the rate of 55 kobos per share. This decision was made at the company's Annual General Meeting held on the 7th of May 2021.
GSK plc is a British multinational pharmaceutical company that specializes in developing and manufacturing prescription drugs and vaccines. The company has a strong presence in Nigeria and is committed to improving the health and well-being of Nigerians through its products and services.
Conclusion
The approval of the dividend payment by GSK plc shareholders is a positive development for the company and its investors. It shows that the company is committed to creating value for its shareholders and rewarding them for their investment. With its strong presence in Nigeria and its focus on improving healthcare, GSK plc is well-positioned for long-term growth and success.
Keywords: GSK plc, dividend, shareholders, Nigeria, pharmaceuticals
